ClinicalTrialsFinder

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis Clinical Trials in Las Vegas, Nevada

1 recruitingLas Vegas, Nevada

Showing 1–1 of 1 trials

Recruiting
Phase 2

Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age

Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis
Dynavax Technologies Corporation148 enrolled3 locationsNCT07207408